E
Emmanuel Sorbets
Researcher at University of Paris
Publications - 68
Citations - 1032
Emmanuel Sorbets is an academic researcher from University of Paris. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 16, co-authored 66 publications receiving 774 citations. Previous affiliations of Emmanuel Sorbets include Imperial College London & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry
Senthil Selvaraj,Ph. Gabriel Steg,Yedid Elbez,Emmanuel Sorbets,Laurent J. Feldman,Kim A. Eagle,E. Magnus Ohman,Jacques Blacher,Deepak L. Bhatt,Reach Registry Investigators +9 more
TL;DR: In an international cohort of high-risk subjects, PP, a readily available hemodynamic parameter, is associated with multiple adverse cardiovascular outcomes and provides prognostic utility beyond that of mean arterial pressure.
Journal ArticleDOI
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Arthur Darmon,Deepak L. Bhatt,Yedid Elbez,Victor Aboyans,Sonia S. Anand,Jackie Bosch,Kelley R. Branch,Stuart J. Connolly,Leanne Dyal,John W. Eikelboom,Keith A.A. Fox,Katalin Keltai,Jeffrey L. Probstfield,Salim Yusuf,Jérémie Abtan,Emmanuel Sorbets,Kim A. Eagle,Gregory Ducrocq,Gregory Ducrocq,Philippe Gabriel Steg +19 more
TL;DR: The proportion of patients eligible for the COMPASS trial within the Reduction of Atherothrombosis for Continued Health (REACH) registry is described, suggesting good external applicability, and COMPASS-Eligible patients experienced a higher rate of the primary outcome compared with COMPASS participants in the aspirin alone treatment arm.
Journal ArticleDOI
Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system.
Didier Tchetche,Thomas Modine,Bruno Farah,Olivier Vahdat,Arnaud Sudre,Mohamad Koussa,Corinne Lereun,Mohammed Nejjari,Michael Choby,Julien Rosencher,Emmanuel Sorbets,Jean Fajadet +11 more
TL;DR: The Accutrak™ catheter seems to be helpful in achieving higher and more predictable implants, and operators could standardise their technique to place the CoreValve® prostheses less than 6 mm below the aortic annulus.
Journal ArticleDOI
Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study.
Dominique Salmon-Ceron,Dorsaf Slama,Thomas De Broucker,Marina Karmochkine,Juliette Pavie,Emmanuel Sorbets,Nicolas Etienne,Dominique Batisse,Gabriela Spiridon,Valérie Le Baut,Jean-François Meritet,Eric Pichard,Florence Canoui-Poitrine +12 more
TL;DR: The clinical, biological and maging profile of patients with initial mild to oderate forms of COVID-19, complain of persistent or resurgent symptoms is described in order to suggest a classification of the symptoms and raise hypotheses about their pathophysiology.
Journal ArticleDOI
In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis
Juan Antonio Moreno,Almudena Ortega-Gomez,Sandrine Delbosc,Nathalie Beaufort,Emmanuel Sorbets,Liliane Louedec,Marina Esposito-Farèse,Florence Tubach,Florence Tubach,Antonino Nicoletti,Antonino Nicoletti,Philippe Gabriel Steg,Philippe Gabriel Steg,Jean-Baptiste Michel,Jean-Baptiste Michel,Laurent J. Feldman,Laurent J. Feldman,Olivier Meilhac,Olivier Meilhac +18 more
TL;DR: It is suggested that neutrophil elastase promotes CD163 shedding, resulting in a decreased clearance of Hb by macrophages, which may favour plaque destabilization.